EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
2.380
-0.030 (-1.24%)
Dec 4, 2025, 4:00 PM EST - Market closed
EDAP TMS Market Cap
EDAP TMS has a market cap or net worth of $88.99 million as of December 4, 2025. Its market cap has decreased by -2.42% in one year.
Market Cap
88.99M
Enterprise Value
89.14M
1-Year Change
-2.42%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since December 31, 2001, EDAP TMS's market cap has increased from $17.50M to $88.99M, an increase of 408.53%. That is a compound annual growth rate of 7.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 90.20M | 9.60% |
| Dec 31, 2024 | 82.30M | -57.88% |
| Dec 29, 2023 | 195.40M | -45.60% |
| Dec 30, 2022 | 359.20M | 86.11% |
| Dec 31, 2021 | 193.00M | 28.07% |
| Dec 31, 2020 | 150.70M | 17.28% |
| Dec 31, 2019 | 128.50M | 139.74% |
| Dec 31, 2018 | 53.60M | -34.95% |
| Dec 29, 2017 | 82.40M | -1.08% |
| Dec 30, 2016 | 83.30M | -18.89% |
| Dec 31, 2015 | 102.70M | 102.17% |
| Dec 31, 2014 | 50.80M | -6.27% |
| Dec 31, 2013 | 54.20M | 99.26% |
| Dec 31, 2012 | 27.20M | 23.64% |
| Dec 30, 2011 | 22.00M | -64.23% |
| Dec 31, 2010 | 61.50M | 132.95% |
| Dec 31, 2009 | 26.40M | 100.00% |
| Dec 31, 2008 | 13.20M | -68.79% |
| Dec 31, 2007 | 42.30M | -7.44% |
| Dec 29, 2006 | 45.70M | 4.10% |
| Dec 30, 2005 | 43.90M | 48.31% |
| Dec 31, 2004 | 29.60M | 112.95% |
| Dec 31, 2003 | 13.90M | 49.46% |
| Dec 31, 2002 | 9.30M | -46.86% |
| Dec 31, 2001 | 17.50M | - |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |